Results 241 to 250 of about 44,589 (256)

Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells

Clinical and Experimental Ophthalmology, 2008
Masahiko Ayaki
exaly  

pH Stability of ophthalmic solutions

Optometry - Journal of the American Optometric Association, 2004
Antonio Lopez-Alemany
exaly  

In Situ Gelling of Alginate/Pluronic Solutions for Ophthalmic Delivery of Pilocarpine

Biomacromolecules, 2004
Hong-Ru Lin
exaly  

Cyclodextrins in ophthalmic drug delivery

Advanced Drug Delivery Reviews, 1999
Thorsteinn Loftsson
exaly  

Bridging the cancer divide: Policy and structural solutions for equity in the United States

Ca-A Cancer Journal for Clinicians
Inimfon Jackson
exaly  

Monitored anaesthesia in elderly ophthalmic patients

Lancet, The, 2002
exaly  

Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC–MS/MS

International Journal of Pharmaceutics, 2013
Zhidong Liu, Li Zhang
exaly  

A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye

Journal of Controlled Release, 1997
Smadar Cohen
exaly  

Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin

International Journal of Pharmaceutics, 2007
Wenwen Chen
exaly  

Effects of bypass on ocular ischaemic syndrome caused by reversed flow in the ophthalmic artery

Lancet, The, 1999
exaly